<DOC>
	<DOCNO>NCT02167815</DOCNO>
	<brief_summary>This investigation Post Marketing Follow-Up Study Mepilex XT conduct part Mölnlycke Health Care 's quality system . The primary objective evaluate performance dress use intend exude Venous Leg Ulcers ( VLUs ) inflammatory granulate stage wound heal process .</brief_summary>
	<brief_title>A Multicenter , Post Marketing Clinical Follow ( PMCF ) Investigation Evaluate Performance Safety Soft Silicone Foam Dressing Evaluate Performance Standard Care Exuding Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Venous Leg Ulcer 2 . Exuding wound 3 . Wound surface cover sloughy tissue* ( debridement ) 4 . Wound size ≥ 6 cm2 5 . In case multiple wound , target wound must ≥ 3cm distant wound . 6 . Wound suitable treatment relevant primary dressing** 7 . Male female , 18 year age 8 . Signed Informed Consent Sloughy tissue define wet , yellowbrown fibrinous tissue present wound bed ** Mepilex XT intervention group . Standard care observation group 1 . More two product 15 cm x15 cm need cover whole wound affect periwound area 2 . Wound cavity and/or fistula 3 . Full thickness burn 4 . Exposed tendon and/or fascia 5 . Bleeding wound 6 . Malignant fungating wound 7 . Wound age &gt; 12 month 8 . Use antimicrobial dressing topical agent antiseptic , local antibiotic steroid within 7 day inclusion wound intend include 9 . Untreated limb ischemia ( accord investigator 's judgement ) time inclusion 10 . Subject suitable investigation accord investigator 's judgement 11 . Subject include ongoing clinical investigation could interfere investigation , judge investigator 12 . Known allergy/hypersensitivity component primary dress</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>